Protheragen has expanded its 13C/14C-labeled compound portfolio to support research in metabolic pathways, pharmacokinetics, breath assays, and biochemical tracing. The expanded lineup improves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback